Medicover AB
F:5M0B

Watchlist Manager
Medicover AB Logo
Medicover AB
F:5M0B
Watchlist
Price: 19.16 EUR 3.57% Market Closed
Market Cap: €2.9B

Wall St Price Targets

5M0B Price Targets Summary
Medicover AB

Wall Street analysts forecast 5M0B stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 5M0B is 31.32 EUR with a low forecast of 25.32 EUR and a high forecast of 36.92 EUR.

Lowest Forecast
Price Target
25.32 EUR
32% Upside
Average Forecast
Price Target
31.32 EUR
63% Upside
Highest Forecast
Price Target
36.92 EUR
93% Upside
Medicover AB Competitors:
Price Targets
COHU
Cohu Inc
-8% Downside
SRFM
Surf Air Mobility Inc
544% Upside
ALG
Alamo Group Inc
29% Upside
OGI
OrganiGram Holdings Inc
125% Upside

Revenue
Forecast

19% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
19% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 9 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 3 years is 12%.

Gross Profit
Forecast

18% / Year
Past Growth
41% / Year
Estimated Growth
Estimates Accuracy
-46%
Average Miss
18% / Year
Past Growth
41% / Year
Estimated Growth
Estimates Accuracy
-46%
Average Miss

Over the last 9 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 41%.

Operating Income
Forecast

25% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
25% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

Over the last 9 years, the compound annual growth rate for Operating Income has been 25%. The projected CAGR for the next 3 years is 24%.

Pre-Tax Income
Forecast

26% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
26% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 26%. The projected CAGR for the next 3 years is 33%.

Net Income
Forecast

32% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss
32% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Over the last 9 years, the compound annual growth rate for Net Income has been 32%. The projected CAGR for the next 3 years is 29%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 5M0B's stock price target?
Price Target
31.32 EUR

According to Wall Street analysts, the average 1-year price target for 5M0B is 31.32 EUR with a low forecast of 25.32 EUR and a high forecast of 36.92 EUR.

What is the Revenue forecast for Medicover AB?
Projected CAGR
12%

Over the last 9 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 3 years is 12%.

What is the Gross Profit forecast for Medicover AB?
Projected CAGR
41%

Over the last 9 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 41%.

What is the Operating Income forecast for Medicover AB?
Projected CAGR
24%

Over the last 9 years, the compound annual growth rate for Operating Income has been 25%. The projected CAGR for the next 3 years is 24%.

What is the Pre-Tax Income forecast for Medicover AB?
Projected CAGR
33%

Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 26%. The projected CAGR for the next 3 years is 33%.

What is the Net Income forecast for Medicover AB?
Projected CAGR
29%

Over the last 9 years, the compound annual growth rate for Net Income has been 32%. The projected CAGR for the next 3 years is 29%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett